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Objective. To describe the proﬁle of breast cancer in the patients attending the radiation therapy unit of Yaounde General
Hospital. Method. From 1989 to 2009, we conducted a descriptive retrospective study based on the register and medical records
of patients. Results. During the study period, 531 breast cancer patients were recorded of which 0.75% were male. Age range
was 18 to 82 years, with a mean of 45.17 years. Out of these, 66.1% were less than 50 years old and 31.9% less than 40. Self
detection was the discovery method in most cases (95.34% of patients). Mean delay before presentation at hospital was 10.35
months, and 54.94% had used traditional medicine before medical evaluation. Metastasis and locally advanced breast cancer
at diagnosis were present in 08.13% and 62.78%, respectively. Mastectomy was used in 88.08% of patients. Conclusion.T h e
study reinforces the position occupied by late presentation and advanced stage at diagnosis of breast cancer proﬁle in developing
countries.
1.Introduction
Breast cancer is now the most frequent cancer of women
worldwide with up to a million cases annually [1]. In
Cameroon, according to the Globocan 2010 estimation,
breast cancer is the most frequent cancer in women before
the cervical cancer with an incidence rate of 27.9 per
100,000[2].Breastcancerisbecominganincreasinglyurgent
problem in low-resource regions, where incidence rates have
beenincreasingbyupto5%annually[3].InIbadan,Nigeria,
the incidence of breast cancer increased, from 33.6 per
100,000 in 1992 to 116 per 100,000 in 2001 [4]. In Uganda,
breast cancer incidence has doubled from 11 per 100,000 in
1961 to 22 per 100,000 in 1995 [5].
This increase in the incidence of breast cancer in African
countries has been attributed to the adoption of westernized
lifestyles; however, improvement in data collection and
reporting may also be contributing factors [6, 7].
Breast cancers in African countries are typically charac-
terized by a relatively advanced stage distribution which is at
least partially explained by delayed presentation for medical
evaluation, inadequate diagnosis by some inexperienced
health providers leading to time lost, limited available
medical technology for cancer screening, diagnosis, and
treatment [6, 8, 9]. This problem of delayed presentation is
multifactorial in nature and varies from one region to the
other. They range from religious belief, prolonged denial,
lack of awareness, poor perceptions about breast cancer, and2 Obstetrics and Gynecology International
readilyavailableandaccessibleherbalandspiritualtreatment
options [10–12].
Thisstudyaimedatdescribingtheproﬁleofbreastcancer
in patients followed up at the Radiation Therapy Unit of the
Yaounde General Hospital situated in Central Africa.
2. Patientsand Methods
We carried out a 20-year descriptive retrospective study from
March 1989 to March 2009 based on the register and medical
records of patients attending the Radiation Therapy Unit
of the Yaounde General Hospital. Yaounde is geographically
situated at the centre region of Cameroon, therefore, the
radiation therapy unit of Yaounde General Hospital receives
patients from all other regions of Cameroon. Cameroon is
a resource-limited country situated in the Central Africa.
In 2010, the Cameroonian population was estimated at
19.7 million inhabitants, with a sex ratio at birth of 1.03
male/female. Forty point ﬁve percent of the population are
less than 14 years, 56.2% are 15–64 years old, and 3.3% are
65 years old and over. The life expectancy is 55.28 years for
women and 53.52 years for men [13].
From the register of all patients attending the Radiation
Therapy Unit, breast cancer patients were selected and for
each case of breast cancer, we noted the medical record
r e f e r e n c e s ,a sw e l la sa g e sa n ds e x e so fp a t i e n t s .T h e n ,
their ﬁles were retrieved from the archives unit. Of the
531 cases of breast cancers patients selected from the
register, 344 medical ﬁles were complete and 187 (35%) were
incomplete,unexploitable,ormissing.Inthecompletedﬁles,
we noted details of epidemiological, diagnostic, therapeutic,
and histopathological data.
All data was analyzed using the software package SPSS
version 10. Frequency, mean, and percentage were used to
describe the variables.
3. Results
During the period of March 1989 to March 2009 (20 years),
531 breast cancer patients were recorded in the Radiation
Therapy Unit register, 344 had properly completed ﬁles, and
187 (35%) had incomplete, unexploitable, or missing ﬁles.
3.1. Epidemiological Findings. Of the 531 breast cancer
patients, 527 were females and 4 (0.75%) were males.
The annual frequency of breast cancer patients attending
radiation therapy unit ranged from 3 to 73. We noted that
since2002therewasasteadyincreaseintheannualfrequency
of breast cancer patients (Figure 1).
The ages of patients ranged from 18 to 82 years, with
a mean age of 45.17 ± 12.2 years. The peak age range was
40–49 years. However, (351) 66.1% of breast cancer patients
were under 50 years, and (169) 31.9% were less than 40
(Figure 2) .T h e r ew e r e6c a s e s( 1 . 1 2 % )o fb i l a t e r a lb r e a s t
cancer. Concerning the gynecologic and reproductive risk
factors, the age at menarche ranged from 9 to 19 years, with a
mean of 13.53 ± 4.09 years, while menopause occurred at
39 to 57 years old with a mean of 50.54 ± 4.16 years. At
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Figure 1: Yearly distribution of breast cancer patients followup at
the Radiation Therapy Unit.
Table 1: Complaints of breast cancer patients at ﬁrst medical
evaluation.
Complaints at ﬁrst
medical visit
Number of patients
n = 344 Percentage
Breast mass 344 100
Breast pain 116 33,72
Skin ulceration 8 02,32
Skin retraction 4 01.16
Skin nodule 28 08.13
Axillary node 4 01.16
Nipple discharge 14 04.06
the time of ﬁrst medical evaluation, 43.16% patients were
menopausal.
P a r i t yr a n g e df r o m0t o1 4 ,w i t ham e a no f4 . 6 4± 2.6; 38
patients (11.04%) were nulliparous, 138 (40.11%) were para
1 to 3; 168 (48.83%) were more than para 3. The age at the
ﬁ r s tt e r mp r e g n a n c yr a n g e df r o m1 6t o5 2y e a r s ,w i t hm e a n
of 20.25 ± 2.85 years.
Breast feeding was practiced by 86.16% of patients with
the duration ranging from 3 to 30 months and a mean of
13.8 ± 5.4 months. Only 22 (06.39%) patients had a history
of hormonal therapy such as contraceptive pills or hormonal
replacement therapy for menopause before diagnosis of the
breast cancer.
Previous history of breast disease was present in 62
(18.02%) cases; these were 55 benign lumps, 3 breasts
carcinomas, and 3 breast abscesses. A Family history of
cancer was noted in 30 (8.7%) cases for breast cancer, 2
(0.58%) cases for ovarian cancer, 4 (1.16%) cases for bowel
cancer, and 13 (03.77%) cases for other cancers.
3.2. Disease Presentation. The presenting complaints of
breast cancer patients at ﬁrst medical evaluation are repre-
sented in Table 1. Breast mass was presented by all patients,
and breast pain was noted in 116 (33.72%) patients at the
ﬁrst medical evaluation. The mode of discovery of breast
cancer is represented in Table 2. Breast cancer was discovered
mainly by self detection in 328 (95.34%) cases, clinical breast
examination in 8 (2.32%), and mammographic screening in
2 (0.58%). The duration of symptoms before presentation at
hospital ranged from 7 days to 52 months, with a mean ofObstetrics and Gynecology International 3
Table 2: Distribution of patients by discovery method of breast
cancer.
Discovery method of
breast cancer
Number of patients
n = 344 Percentage
Self detection 328 95.34
Detection by partner 6 01.74
Clinical breast
examination 8 02.32
mammographic
screening 20 . 5 8
Total 344 100
Table 3: Distribution of the breast cancer patients by Clinical TNM
classiﬁcation.
Clinical stage Number of patients
n = 344 Percentage
T1 12 03.48
T2 116 33.72
T3 78 22.67
T4 138 40.11
N+ 296 86.04
M1 28 08.13
Table 4: Histopathological types of the breast cancer of the
population study.
Histopathological types Frequency %
Invasive ductal carcinoma 236 68.60
Invasive lobular carcinoma 38 11.05
Invasive medullary carcinoma 18 5,23
Invasive colloid carcinoma 4 1.16
Invasive cribiform carcinoma 2 0.58
Clear cells carcinoma 2 0.58
Invasive mucinous carcinoma 2 0.58
Invasive tubular carcinoma 2 0.58
Burkitt’s lymphoma 2 0.58
Non hodgkin lymphoma 2 0.58
Invasive phylloides tumour 2 0.58
No-Histopathological diagnosis 34 9.88
Total 344 100.00
10.35 months. Only 48 (13.95%) patients presented within
a month of onset of symptoms, 106 (30.81%) patients
presented within 6 months, and 247 (71.80%) presented
within 1 year of onset of symptoms. However, 189 (54.94%)
breast cancer patients had recourse to traditional medicine
before their ﬁrst medical evaluation.
On the other hand, 216 (62.78%) patients presented
locally advanced breast cancer (T3 and T4), while 296
(86.04%) patients had clinically positive lymph nodes and 28
(08.13%) had metastatic breast cancer at diagnosis (Table 3,
Figures 3 and 4). The histopathological breast cancer types
are presented in Table 4. The commonest histopathological
diagnosis was invasive ductal carcinoma 236 (68,60%)
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Figure 2: Age range distribution of breast cancer patients.
Figure 3: Picture of a 24-year-old lady with a bulky left breast
cancer.
followed by invasive lobular carcinoma 38 (11,05%) and
invasive medullary carcinoma 18 (5.23%).
3.3. Treatment Oﬀered. Three hundred and three (88.08%)
patients were treated with simple or radical mastectomy, 37
(10.75%) patients were treated with breast conserving ther-
apy (tumorectomy or quadrantectomy), and for 4 (01.16%)
patients with primary breast lymphoma, no surgery was
done. Chemotherapy was neoadjuvant in 198 (57.55%)
cases, adjuvant in 94 (27.32%) patients, and palliative in
28 (08.13%) cases. In our setting, for neoadjuvant or
adjuvant chemotherapy, the drug combination was CAF
(Cyclophosphamide: 500mg/m2, adriamycin: 50mg/m2,5 -
ﬂuorouracil: 500mg/m2)e v e r y2 1d a y sf o r6c y c l e s .
Hormonal therapy especially with tamoxifen was pro-
posed systematically to all patients (but not for the 4 cases
of lymphoma) because it was not possible in our setting to
test for hormonal receptors of breast tumor. Two hundred
and eighty-six (83.13%) patients eﬀectively used hormonal
therapy. Three hundred and forty (98.80%) patients were
treated with radiation therapy after surgery, and 4 (1.2%)
cases who had primary breast lymphoma were treated with
neoadjuvant chemotherapy followed by radiation therapy.
Radiation therapy was delivered by a cobalt unit. The dose
of 50Gy over 5 weeks was given for postmastectomy patients
when indicated. However, in cases of breast conserving4 Obstetrics and Gynecology International
Figure 4: Picture of a 35-year-old lady with advanced left breast
cancer.
treatment, a dose of 50Gy over 5 weeks with a boost dose
of 15Gy to the tumor site was administrated.
Most of the breast cancer patients followed up at the
radiation therapy unit returned to their regions of origin at
the end of the treatment for the posttherapeutic followup.
This makes it diﬃcult in this survey to determine the
mortality linked to breast cancer.
4. Discussion
The limitation of this study and which is a concern to
researchers is that 33% of medical ﬁles were incomplete,
unexploitable, or missing. The problem of medical records
is a big concern in the developing countries, and it represents
a major handicap for medical statistics and research in this
setting.
Breast cancer is an urgent public health problem in high-
resource regions, and in recent years, it is becoming an
urgent problem in low resource regions, where incidence
r a t e sh a v eg o n eu pt o5 %y e a r l y[ 3].Few studies are available
for the study of time trends in Africa, but some increases in
incidence are apparent, for example, in Ibadan, Nigeria, and
in Kampala, Uganda, between 1960 and late 1990 [4, 5, 7].
The steady increase in the annual frequency of breast
cancer patients attending the radiation therapy unit since
2002 in our study could be explained probably by the
increasing incidence of breast cancer in our population
and/or the impact of recent public health campaigns for
breast health awareness, earlier diagnosis by breast self-
examinations, and the early hospital presentation in case of
any signs of breast lesions.
Breast cancer is a disease of older women in developed
countries, which is contrary to ﬁndings in developing
countries [3, 10]. In this study, 66.1% of patients were
less than 50 years old and the mean age at diagnosis was
45.17 ± 12.2 years. These results approach the other African
countries where the majority of breast cancer patients are
premenopausal women. In contrast, in North America and
Europe, the incidence rates among postmenopausal women
are rising [10, 14]. It has been postulated that the lower
postmenopausal breast cancer incidence rates observed for
Africans are a result of demographic factors, especially
population age and overall life expectancy [15]. Like other
African countries, Cameroonians are a younger population
with 40.5% of people less than 14 years of age and the
life expectancy at birth of women estimated at 55.28 years
[13].
The gynecologic and reproductive patterns within
African populations tend to result in fewer ovulatory cycles
over a lifetime, and this contributes to a decrease in breast
cancer risk. Although published studies have generally been
small, the trends observed have included late menarche,
multiparity, initiation of childbearing at young ages, and
prolonged breastfeeding [14]. The ﬁndings in this study
corroborate African gynecologic and reproductive patterns.
Breast cancers in African countries are typically charac-
terized by a relatively advanced stage distribution [3]. In this
study, 62.78% of patients presented with locally advanced
breast cancer (T3 and T4), 86.04% patients had clinically
positive lymph nodes, and 08.13% patients had metastatic
breast cancer at diagnosis. Other retrospective studies in
NigeriaandZimbabwehavereportedthat70–90%ofAfrican
women present with Stage III or IV disease at diagnosis
[15, 16].
The advanced stage of breast cancer at diagnosis should
be explained by the absence of national breast cancer
screening program and the delayed presentation at the
hospital.
Like other developing countries, there is no national
screening program of breast cancer in Cameroon; however
there are periodical mass campaigns for breast health
awareness and clinical breast examination organized by the
public health ministry. The result of this study conﬁrms
the poor screening system in Cameroon, because 95.34% of
breast cancer were revealed by patient’s self-detection, and
only a few cases were revealed by breast clinical examination
(2.38%) or by mammographic screening (0.58%).
Late presentation at the hospital is a common phe-
nomenon in developing countries. This is well demonstrated
in this study and in many studies on breast cancer in other
developing countries [9, 10, 12, 16].
In our study, the mean delay from ﬁrst signs of breast
cancer to ﬁrst medical evaluation ranged from 7 days to 52
months with a mean of 10.35 months. More than half of
these patients had solicited traditional medicine before their
ﬁrst medical evaluation in this study. This high recourse of
breastcancerpatienttotraditionalmedicineatﬁrstintention
should partially explain the late presentation at the hospital.
The reasons for the recourse to the traditional medicine
(herbal preparations and visiting spiritual houses) at ﬁrst
intention in our context included the lack of awareness on
the breast cancer, cultural beliefs, ignorance, the fear of
mastectomy as a treatment modality in the hospitals, and the
inabilitytopayformedicalcareintheabsenceofanadequate
health insurance.
In this study, there was not a single case of carcinoma in
situ, which accounted for more than 10% of cases in devel-
opedcountriesowingtotheincreaseduseofmammographic
screening in these countries. The histopathological nature of
breastcancerwasthatofinﬁltratingductalcarcinomainover
68.60% corroborates other African studies [7].Obstetrics and Gynecology International 5
Treatment of breast cancer is multidisciplinary in nature.
Various breast-conserving surgeries such as lumpectomy,
segmentectomy, and quadrantectomy instead of mastectomy
may be adequate in patients with early-stage cancers. The
standard approach to locally advanced breast cancer requires
initial neoadjuvant chemotherapy and thereafter the use of
modiﬁed radical mastectomy and then radiation therapy
[17]. In our study, surgery was mainly mastectomy, the
reason being the advanced stage of the disease at diagnosis,
which did not permit breast conserving therapy, and also
the inexperience of some surgeons at the breast conserving
approach.
Chemotherapy plays a major role in the treatment of
breastcancer.Inthisstudy,chemotherapywasmainlyneoad-
juvant (55.81%), which was concordant with the higher
proportion of locally advanced breast cancer at presentation.
Radiation therapy assists in controlling locoregional
diseases, this study was done in the Radiation Therapy Unit
and all patients received radiation therapy which was mainly
adjuvant.
The beneﬁt from endocrine therapy is considerable
enough, such that in the absence of hormone receptor
determination (unknown receptor status), a breast cancer
should be treated as receptor positive [17]. In this study,
in the absence of hormone receptor status, tamoxifen was
proposed to all patients excluding lymphoma cases and was
used by 84.11%. Fifteen point eighty nine percent of patients
could not aﬀord tamoxifen. The aromatase inhibitors or
inactivators (anastrozole, letrozole, and exemestane) have
demonstrated better eﬃcacy than tamoxifen, but these
are not easily available and too expensive for patients in
developing countries to beneﬁt from their eﬃcacy.
5. Conclusion
Breast cancer in Cameroon follows a proﬁle similar to other
developing countries with late presentation and advanced
stage at diagnosis. The absence of screening programs and
recourse at ﬁrst intention to readily and more accessible
traditional medicine should be the main reasons. However,
breast health awareness, training of health providers on
clinical breast examination, and the women on breast self-
examination should be useful for enhancing early diagnosis
and providing the possibility of breast conservation in these
setting where mammographic screening programs seem
not to be feasible. Also the Public Health Ministry should
ensure access to appropriate, aﬀordable diagnostic tests, and
treatment, which are lacking in most developing countries.
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